Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05294718 |
Other study ID # |
MS-103-2013 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 1, 2017 |
Est. completion date |
August 1, 2022 |
Study information
Verified date |
March 2023 |
Source |
Kasr El Aini Hospital |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
A prospective, randomized comparative study where investigators present results of off pump
bidirectional Glenn operation done using either a venoatrial shunt or external shunt to
decompress superior vena cava during clamping.
Description:
The bidirectional Glenn shunt (BDG) is performed for cyanotic congenital heart defects, with
single-ventricle pathology . The BDG is usually performed with cardiopulmonary bypass (CPB)
with its associated complications. The conduct of this operation without CPB can be
associated with elevation of superior vena caval (SVC) pressure that may lead to neurological
damage.
However, the safety of performing BDG without CPB reported by many authors but with some
decompression techniques of the SVC at the time of clamping
Objective: investigators present results of off pump bidirectional Glenn operation done using
either a venoatrial shunt or external shunt to decompress superior vena cava during clamping.
Design A prospective, randomized comparative study Setting: Single tertiary care cardiac
center Participants 30 patients with functional single ventricle who will go off pump
bidirectional Glenn.
Interventions: The patients will be randomly assigned into two groups: Group I (n = 15),
where it will be done with a veno-atrial shunt(internal), and Group II (n = 15), where it
will be done with an external shunt. All patients will go a complete neurological examination
both preoperatively as well as postoperatively Intraoperative data will be collected and
analyzed at the following time points: pre-clamping (post induction), during clamping and
after de-clamping of SVC. variables such as arterial oxygen saturation (SaO2), systolic blood
pressure (SBP), mean arterial blood pressure (MAP), diastolic blood pressure (DBP), and
hematocrit, CVP, SVC pressure, cerebral perfusion pressure (CPP= MAP-CVP), PaO2, PaCO2 and
ScvO2 will be analyzed.
Postoperatively, the patients will be stabilized in the intensive care unit (ICU) and after
monitoring the SVC pressure for 12 h, the internal jugular vein cannula will be removed to
prevent any jugular vein thrombosis. The patients will start aspirin (5 mg/kg/day), which
will be continued indefinitely.